Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Pharmacological Research|November 18, 2025
Psychotropic effects of GLP-1R agonistsLoredana Bucciarelli, Vincenzo Cimino, Bernardo Dell'Osso, et al.Metabolism: Clinical and Experimental|December 19, 2025
Metabolic and immune dysfunction at the crossroads between type 1 diabetes and neurodegenerationFrancesca D'Addio, Loredana Bucciarelli, Maria Elena Lunati, et al.Minerva Endocrinology|January 13, 2021
Obesity and COVID-19: the ominous duet affecting the renin-angiotensin systemLivio Luzi, Loredana Bucciarelli, Anna Ferrulli, et al.Acta Diabetologica|November 7, 2025
Muscle loss and GLP-1R agonists useGiada Rossi, Loredana Bucciarelli, Chyrell-Lyn Mananguite, et al.Diabetes Care|June 4, 2026
Pathophysiology and Treatment of Type 1 Diabetes in Older AdultsAlessandra Petrelli, Nicholas J Thomas, Suzy V Hope, et al.Current Atherosclerosis Reports|April 5, 2002
Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetesThoralf Wendt, Loredana Bucciarelli, Wu Qu, et al.Annals of the New York Academy of Sciences|July 23, 2005
Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injuryMichiyo Kaneko, Loredana Bucciarelli, Yuying C Hwang, et al.Pharmacological Research|November 14, 2025
Glycometabolic cardiac dysfunction in HFpEF: Lessons from multi-omics studiesSusanna Longo, Rocco Mollace, Viviana Casagrande, et al.Cardiovascular Diabetology|June 29, 2013
Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetesAntonio Ceriello, Anna Novials, Emilio Ortega, et al.Diabetes Care|October 17, 2013
Vitamin C further improves the protective effect of glucagon-like peptide-1 on acute hypoglycemia-induced oxidative stress, inflammation, and endothelial dysfunction in type 1 diabetesAntonio Ceriello, Anna Novials, Emilio Ortega, et al.Pageof 4